Valproic Acid Increased Autophagic Flux in human Multiple Myeloma Cells in Vitro

Biomed Pharmacother. 2020 Jul:127:110167. doi: 10.1016/j.biopha.2020.110167. Epub 2020 Apr 25.

Abstract

Background: To investigate the effects of valproic acid (VPA) on autophagic flux in multiple myeloma (MM) cells.

Methods and results: Cell proliferation was assayed by the Cell Counting Kit-8 assay. The qRT-PCR was used to measure the expressions of LC3-II at mRNA level. Autophagic flux was measured by LC3-II turnover using western blot analysis and flow cytometry using the fluorescent dye Cyto-ID. An assay using the RFP-GFP-LC3 tandem construct was performed to monitor autophagic flux. Cell proliferation assay showed that VPA could inhibit the proliferation of MM cells and the inhibitory effects were enhanced with the extension of time. The qRT-PCR and western blot showed that the expression level of LC3-II in the VPA plus CQ group was significantly higher than that in CQ group. Cyto-ID autophagy test showed that the intracellular average fluorescence intensity in VPA plus CQ group was significantly higher than that in control and VPA group (all p < 0.001). The results of RFP-GFP-LC3 tandem construct showed that the numbers of yellow puncta and red puncta in VPA group was higher than that in control group.

Conclusions: VPA could inhibit the proliferation of MM cells and the inhibitory effects were enhanced with the extension of time. VPA could enhance autophagic flux in MM cells, and the increase of autophagosomes was caused by autophagy enhancement rather than inhibition. These findings provided rationale for the treatment of MM with VPA.

Keywords: LC3-II; autophagic flux; autophagy; multiple myeloma; valproic acid.

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Autophagosomes / drug effects
  • Autophagosomes / metabolism
  • Autophagy / drug effects*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Microtubule-Associated Proteins / genetics
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / genetics
  • Multiple Myeloma / pathology
  • Valproic Acid / pharmacology*

Substances

  • Antineoplastic Agents
  • MAP1LC3B protein, human
  • Microtubule-Associated Proteins
  • Valproic Acid